Skip to main content
Federal & State Lawfederalstatelaw.com
Home/Federal/Bills (Live)
HOUSE 27119th CongressReferred to the House Committee on Transportation and Infrastructure.

Expressing support for the work of open water lifeguards as first responders and emergency response providers.

Last Action
4/10/2025

Actions

  • 2025-02-10Received in the Senate and Read twice and referred to the Committee on the Judiciary.
  • 2025-02-06Motion to reconsider laid on the table Agreed to without objection.
  • 2025-02-06On passage Passed by the Yeas and Nays: 312 - 108 (Roll no. 33). (text: CR H520-522)
  • 2025-02-06Passed/agreed to in House: On passage Passed by the Yeas and Nays: 312 - 108 (Roll no. 33). (text: CR H520-522)
  • 2025-02-06Considered as unfinished business. (consideration: CR H533-535)
  • 2025-02-06POSTPONED PROCEEDINGS - At the conclusion of debate on the Trahan amendment No. 2, the Chair put the question on agreeing to the amendment and by voice vote, announced that the noes prevailed. Mrs. Trahan demanded the yeas and nays and the Chair postponed further proceeding until a time to be announced.
  • 2025-02-06DEBATE - Pursuant to the provisions of H. Res. 93, the House proceeded with 10 minutes of debate on the Trahan amendment No. 2.
  • 2025-02-06DEBATE - The House proceeded with one hour of debate on H.R. 27.
  • 2025-02-06Rule provides for consideration of H.R. 27 with 1 hour of general debate. Motion to recommit allowed. The resolution makes in order only the further amendment printed in Part B of the Rules Committee report.
  • 2025-02-06Considered under the provisions of rule H. Res. 93. (consideration: CR H520-533)
  • 2025-02-05Rule H. Res. 93 passed House.
  • 2025-02-04Rules Committee Resolution H. Res. 93 Reported to House. Rule provides for consideration of H.R. 27 with 1 hour of general debate. Motion to recommit allowed. The resolution makes in order only the further amendment printed in Part B of the Rules Committee report.
  • 2025-01-03Referred to the Committee on Energy and Commerce, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
  • 2025-01-03Referred to the Committee on Energy and Commerce, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
  • 2025-01-03Introduced in House

Showing 15 of 16 actions. Full history on Congress.gov.

CRS Summary

As of 2025-01-03 (00)

Halt All Lethal Trafficking of Fentanyl Act or the HALT Fentanyl Act

This bill permanently places fentanyl-related substances as a class into schedule I of the Controlled Substances Act. A schedule I controlled substance is a drug, substance, or chemical that has a high potential for abuse; has no currently accepted medical value; and is subject to regulatory controls and administrative, civil, and criminal penalties under the Controlled Substances Act.

Under the bill, offenses involving fentanyl-related substances are triggered by the same quantity thresholds and subject to the same penalties as offenses involving fentanyl analogues (e.g., offenses involving 100 grams or more trigger a 10-year mandatory minimum prison term).

Additionally, the bill establishes a new, alternative registration process for certain schedule I research.

The bill also makes several other changes to registration requirements for conducting research with controlled substances, including

  • permitting a single registration for related research sites in certain circumstances,
  • waiving the requirement for a new inspection in certain situations, and
  • allowing a registered researcher to perform certain manufacturing activities with small quantities of a substance without obtaining a manufacturing registration.

Finally, the bill expresses the sense that Congress agrees with the interpretation of Controlled Substances Act in United States v. McCray, a 2018 case decided by the U.S. District Court for the Western District of New York. In that case, the court held that butyryl fentanyl, a controlled substance, can be considered an analogue of fentanyl even though, under the Controlled Substances Act, the term controlled substance analogue specifically excludes a controlled substance.

Cosponsors (20)

  • Robert Latta (R-OH)
  • Brett Guthrie (R-KY)
  • Gus Bilirakis (R-FL)
  • Richard Hudson (R-NC)
  • Earl Carter (R-GA)
  • Gary Palmer (R-AL)
  • Neal Dunn (R-FL)
  • Dan Crenshaw (R-TX)
  • John Joyce (R-PA)
  • August Pfluger (R-TX)
  • Diana Harshbarger (R-TN)
  • Kat Cammack (R-FL)
  • Mariannette Miller-Meeks (R-IA)
  • Steve Womack (R-AR)
  • Vern Buchanan (R-FL)
  • Carol Miller (R-WV)
  • John Moolenaar (R-MI)
  • Mike Bost (R-IL)
  • Gabe Evans (R-CO)
  • Scott Fitzgerald (R-WI)

Subjects

  • Administrative law and regulatory procedures
  • Department of Justice
  • Drug trafficking and controlled substances
  • Licensing and registrations
  • Research administration and funding
Read on Congress.gov

Sourced from Congress.gov (public domain).

This is legal information, not legal advice. Laws vary by jurisdiction and change frequently. Always verify current law with official sources and consult a licensed attorney in your jurisdiction for advice on your specific situation.